Detalhe da pesquisa
1.
Obesogens: a unifying theory for the global rise in obesity.
Int J Obes (Lond)
; 48(4): 449-460, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38212644
2.
Environmental Obesogens: Mechanisms and Controversies.
Annu Rev Pharmacol Toxicol
; 59: 89-106, 2019 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30044726
3.
Impacts of food contact chemicals on human health: a consensus statement.
Environ Health
; 19(1): 25, 2020 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32122363
4.
Correction to: Parma consensus statement on metabolic disruptors.
Environ Health
; 16(1): 130, 2017 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29212512
5.
A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals.
Environ Health
; 15(1): 74, 2016 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27412149
6.
Developmental origins of health and disease: a paradigm for understanding disease cause and prevention.
Curr Opin Pediatr
; 27(2): 248-53, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25635586
7.
Parma consensus statement on metabolic disruptors.
Environ Health
; 14: 54, 2015 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26092037
8.
Manufacturing doubt about endocrine disrupter science--A rebuttal of industry-sponsored critical comments on the UNEP/WHO report "State of the Science of Endocrine Disrupting Chemicals 2012".
Regul Toxicol Pharmacol
; 73(3): 1007-17, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26239693
9.
The Conflict between Regulatory Agencies over the 20,000-Fold Lowering of the Tolerable Daily Intake (TDI) for Bisphenol A (BPA) by the European Food Safety Authority (EFSA).
Environ Health Perspect
; 132(4): 45001, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38592230
10.
A vision for safer food contact materials: Public health concerns as drivers for improved testing.
Environ Int
; 180: 108161, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37758599
11.
Obesogens and Obesity: State-of-the-Science and Future Directions Summary from a Healthy Environment and Endocrine Disruptors Strategies Workshop.
Am J Clin Nutr
; 118(1): 329-337, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37230178
12.
Developmental origins of non-communicable disease: implications for research and public health.
Environ Health
; 11: 42, 2012 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-22715989
13.
Obesity I: Overview and molecular and biochemical mechanisms.
Biochem Pharmacol
; 199: 115012, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35393120
14.
Obesity III: Obesogen assays: Limitations, strengths, and new directions.
Biochem Pharmacol
; 199: 115014, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35393121
15.
Obesity II: Establishing causal links between chemical exposures and obesity.
Biochem Pharmacol
; 199: 115015, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35395240
16.
Lou Guillette--in memorandum.
Mol Reprod Dev
; 82(10): Fmi-v, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26457800
17.
Data integration, analysis, and interpretation of eight academic CLARITY-BPA studies.
Reprod Toxicol
; 98: 29-60, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32682780
18.
Early-life prevention of non-communicable diseases.
Lancet
; 381(9860): 3-4, 2013 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23290956
19.
The developmental basis of disease: Update on environmental exposures and animal models.
Basic Clin Pharmacol Toxicol
; 125 Suppl 3: 5-13, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30265444
20.
History of the Obesogen Field: Looking Back to Look Forward.
Front Endocrinol (Lausanne)
; 10: 14, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30761083